Bruker Corp. (BRKR)
57.00
-2.56
(-4.30%)
USD |
NASDAQ |
Aug 24, 16:00
57.00
0.00 (0.00%)
After-Hours: 20:00
Bruker EPS Diluted (Quarterly) : -0.413 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.413 |
| March 31, 2026 | 0.0229 |
| December 31, 2025 | 0.0977 |
| September 30, 2025 | -0.4111 |
| June 30, 2025 | 0.0501 |
| March 31, 2025 | 0.1146 |
| December 31, 2024 | 0.0901 |
| September 30, 2024 | 0.2691 |
| June 30, 2024 | 0.0514 |
| March 31, 2024 | 0.3489 |
| December 31, 2023 | 1.408 |
| September 30, 2023 | 0.5981 |
| June 30, 2023 | 0.3866 |
| March 31, 2023 | 0.5183 |
| December 31, 2022 | 0.6586 |
| September 30, 2022 | 0.5929 |
| June 30, 2022 | 0.3304 |
| March 31, 2022 | 0.4069 |
| December 31, 2021 | 0.4964 |
| September 30, 2021 | 0.57 |
| June 30, 2021 | 0.3767 |
| March 31, 2021 | 0.3701 |
| December 31, 2020 | 0.448 |
| September 30, 2020 | 0.3519 |
| June 30, 2020 | 0.1558 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0676 |
| December 31, 2019 | 0.4414 |
| September 30, 2019 | 0.394 |
| June 30, 2019 | 0.2316 |
| March 31, 2019 | 0.1951 |
| December 31, 2018 | 0.4962 |
| September 30, 2018 | 0.2757 |
| June 30, 2018 | 0.1987 |
| March 31, 2018 | 0.172 |
| December 31, 2017 | -0.0218 |
| September 30, 2017 | 0.2331 |
| June 30, 2017 | 0.15 |
| March 31, 2017 | 0.13 |
| December 31, 2016 | 0.43 |
| September 30, 2016 | 0.29 |
| June 30, 2016 | 0.09 |
| March 31, 2016 | 0.14 |
| December 31, 2015 | 0.36 |
| September 30, 2015 | 0.07 |
| June 30, 2015 | 0.13 |
| March 31, 2015 | 0.04 |
| December 31, 2014 | 0.15 |
| September 30, 2014 | 0.03 |
| June 30, 2014 | 0.10 |
| March 31, 2014 | 0.05 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Thermo Fisher Scientific, Inc. | 4.679 |
| Agilent Technologies, Inc. | 1.198 |
| Bio-Rad Laboratories, Inc. | 13.85 |
| Danaher Corp. | 1.230 |
| Illumina, Inc. | 1.353 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -50.90M |
| Revenue (Quarterly) | 838.50M |
| Total Expenses (Quarterly) | 890.50M |
| Enterprise Value | 10.73B |
| Gross Profit Margin (Quarterly) | 49.65% |
| Profit Margin (Quarterly) | -6.07% |
| Earnings Yield | -1.23% |
| Operating Earnings Yield | 3.44% |
| Normalized Earnings Yield | 1.198 |